NRX Pharmaceuticals Inc (NAS:NRXP)
$ 1.8 0.11 (6.51%) Market Cap: 19.35 Mil Enterprise Value: 23.92 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Q4 2022 NRX Pharmaceuticals Inc Earnings Call Transcript

Mar 30, 2023 / 08:30PM GMT
Release Date Price: $7.37 (-1.72%)
Operator

Good afternoon and welcome to the NRx Pharmaceuticals' full-year 2022 results conference call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Suzanne Messere, Stern Investor Relations. Please go ahead.

Suzanne Messere
Stern Investor Relations - IR

Thank you, Danielle. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under US federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectation. Additional information concerning factors that could cause actual results to differ from statements made on this call is contained in our periodic reports filed with the SEC.

The forward-looking statements made during this call speak only as of the date hereof, and the company undertakes no obligation to update or revise the forward-looking statements. Information presented on this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot